glp 1 and parkinson's disease Glucagon-like peptide-1 (GLP-1) receptor agonists neuroinflammation: Implications for neurodegenerative treatment GLP-1 Signalling as a Therapeutic

USD 39.95 Prices may be subject to local taxes which are calculated during checkout Rights and permissions About this article Cite this article Sheridan, C

Microdosing GLP-1 medications can help patients stretch their FDA-approved GLP-1 medication

GLP-1 receptor agonists are a class of medications used primarily to treat type 2 diabetes

All other authors declare that there are no relationships or activities that might bias, or be perceived to bias, their contribution to this manuscript

Every insurance pathway is open

J Clin Endocrinol Metab 109(8):19071947 Halfon M, Phan O, Teta D (2015) Vitamin D: a review on its effects on muscle strength, the risk of fall, and frailty